• Gossamer Bio director Gregory Austin Ciongoli filed an initial Form 3 disclosing a pre-funded warrant for 250 shares of Series A-1 preferred stock.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Gossamer Bio Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001628280-26-063097), on September 22, 2026, and is solely responsible for the information contained therein.